Estimate Recalculated Nov 11, 2024 01:52PM EST
Nimish P Shah does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Instil Bio, Inc., CONSTELLATION PHARMACEUTICALS INC, Apogee Therapeutics, Inc., Shockwave Medical, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and ARCA biopharma, Inc..
Nimish P Shah's CIK is 0001698082
2021 was Nimish P Shah's most active year for acquiring shares with 1 total transactions. Nimish P Shah's most active month to acquire stocks was the month of February. 2021 saw Nimish P Shah paying a total of $0.00 for 52,000 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!